NCT02960737 Dysphagia Evaluation After Stroke- Effect Oral Neuromuscular Training on Swallowing Dysfunction
| NCT ID | NCT02960737 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Umeå University |
| Condition | Dysphagia |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2022-12-01 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2022-12-01 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate the effect of a specific rehabilitation program with an oral device used in stroke patients with persistent oral-and pharyngeal dysphagia.
Eligibility Criteria
Inclusion Criteria: * Persistent dysphagia 12(±3) weeks after STROKE. Exclusion Criteria: * Stroke patients with neurologic or psychiatric disorders or other diseases/conditions that can affect swallowing function. * Unable to collaborate due to other serious diseases and/or to affected general condition.
Contact & Investigator
Patricia Hägglund, PhD/SLP
PRINCIPAL INVESTIGATOR
Umeå University
Frequently Asked Questions
Who can join the NCT02960737 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dysphagia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02960737 currently recruiting?
Yes, NCT02960737 is actively recruiting participants. Contact the research team at patricia.hagglund@umu.se for enrollment information.
Where is the NCT02960737 trial being conducted?
This trial is being conducted at Umeå, Sweden.
Who is sponsoring the NCT02960737 clinical trial?
NCT02960737 is sponsored by Umeå University. The principal investigator is Patricia Hägglund, PhD/SLP at Umeå University. The trial plans to enroll 60 participants.